30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Standardization of 123I- meta-iodobenzylguanidine myocardial sympathetic activity imaging: phantom calibration and clinical applications

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          Myocardial sympathetic imaging with 123I- meta-iodobenzylguanidine ( 123I- mIBG) has gained clinical momentum. Although the need for standardization of 123I- mIBG myocardial uptake has been recognized, the availability of practical clinical standardization approaches is limited. The need for standardization includes the heart-to-mediastinum ratio (HMR) and washout rate with planar imaging, and myocardial defect scoring with single-photon emission computed tomography (SPECT).

          Methods

          The planar HMR shows considerable variation due to differences in collimator design. These camera–collimator differences can be overcome by cross-calibration phantom experiments. The principles of these cross-calibration phantom experiments are summarized in this article. 123I- mIBG SPECT databases were compiled by Japanese Society of Nuclear Medicine working group. Literature was searched based on the words “ 123I- mIBG quantification method”, “standardization”, “heart-to-mediastinum ratio”, and its application to “risk model”.

          Results

          Calibration phantom experiments have been successfully performed in Japan and Europe. The benefit of these cross-calibration phantom experiments is that variation in the HMR between institutions is minimized including low-energy, low–medium-energy and medium-energy collimators. The use of myocardial 123I- mIBG SPECT can be standardized using 123I- mIBG normal databases as a basis for quantitative evaluation. This standardization method can be applied in cardiac event prediction models.

          Conclusion

          Standardization of myocardial 123I- mIBG outcome parameters may facilitate a universal implementation of myocardial 123I- mIBG scintigraphy.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          Epidemiology and risk profile of heart failure.

          Heart failure (HF) is a major public health issue, with a prevalence of over 5.8 million in the USA, and over 23 million worldwide, and rising. The lifetime risk of developing HF is one in five. Although promising evidence shows that the age-adjusted incidence of HF may have plateaued, HF still carries substantial morbidity and mortality, with 5-year mortality that rival those of many cancers. HF represents a considerable burden to the health-care system, responsible for costs of more than $39 billion annually in the USA alone, and high rates of hospitalizations, readmissions, and outpatient visits. HF is not a single entity, but a clinical syndrome that may have different characteristics depending on age, sex, race or ethnicity, left ventricular ejection fraction (LVEF) status, and HF etiology. Furthermore, pathophysiological differences are observed among patients diagnosed with HF and reduced LVEF compared with HF and preserved LVEF, which are beginning to be better appreciated in epidemiological studies. A number of risk factors, such as ischemic heart disease, hypertension, smoking, obesity, and diabetes, among others, have been identified that both predict the incidence of HF as well as its severity. In this Review, we discuss key features of the epidemiology and risk profile of HF.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology.

              This proposal for standardization of (123)I-metaiodobenzylguanidine (iobenguane, MIBG) cardiac sympathetic imaging includes recommendations for patient information and preparation, radiopharmaceutical, injected activities and dosimetry, image acquisition, quality control, reconstruction methods, attenuation, scatter and collimator response compensation, data analysis and interpretation, reports, and image display. The recommendations are based on evidence coming from original or scientific studies whenever possible and as far as possible reflect the current state-of-the-art in cardiac MIBG imaging. The recommendations are designed to assist in the practice of performing, interpreting and reporting cardiac sympathetic imaging. The proposed standardization does not include clinical indications, benefits or drawbacks of cardiac sympathetic imaging, and does not address cost benefits or cost effectiveness; however, clinical settings of potential utility are mentioned. Standardization of MIBG cardiac sympathetic imaging should contribute to increasing its clinical applicability and integration into current nuclear cardiology practice.
                Bookmark

                Author and article information

                Contributors
                +81-762652333 , nakajima@med.kanazawa-u.ac.jp
                Journal
                Clin Transl Imaging
                Clin Transl Imaging
                Clinical and Translational Imaging
                Springer Milan (Milan )
                2281-5872
                2281-7565
                4 May 2017
                4 May 2017
                2017
                : 5
                : 3
                : 255-263
                Affiliations
                [1 ]ISNI 0000 0001 2308 3329, GRID grid.9707.9, Department of Nuclear Medicine, , Kanazawa University, ; 13-1 Takara-machi, Kanazawa, 920-8641 Japan
                [2 ]ISNI 0000000084992262, GRID grid.7177.6, Department of Nuclear Medicine, Academic Medical Center, , University of Amsterdam, ; Amsterdam, The Netherlands
                [3 ]Department of Cardiology, Zaans Medical Center, Zaandam, The Netherlands
                [4 ]ISNI 0000 0001 0265 5359, GRID grid.411998.c, Department of Physics, , Kanazawa Medical University, ; Uchinada, Kahoku, Japan
                Article
                230
                10.1007/s40336-017-0230-2
                5437131
                28596948
                f916dc31-ed52-43a3-b5f6-a851576b6aef
                © The Author(s) 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 10 March 2017
                : 19 April 2017
                Categories
                Expert Review
                Custom metadata
                © Italian Association of Nuclear Medicine and Molecular Imaging 2017

                quantification,heart-to-mediastinum ratio,calibration phantom,conversion coefficient,collimator

                Comments

                Comment on this article